Colchicine Fails to Reduce Major Adverse Cardiovascular Events in Gout Patients with Type 2 Diabetes
A recent study found that colchicine, a common medication for gout, did not reduce the…
A recent study found that colchicine, a common medication for gout, did not reduce the…
Research reveals similar cognitive decline rates in patients following transient ischemic attack and stroke, emphasizing…
Octane to host Cardiovascular Tech Forum 2025, a premier event for innovators and investors in…
The Jayadeva Institute in Hubballi, India, is expediting its construction to address the increasing number…
A new 7.3 million dollar cardio lab has opened in Casper, Wyoming, aiming to reduce…
The UK's National Institute for Health and Care Excellence (NICE) has endorsed pulsed field ablation…